1
/
of
1
Runx1-CBFβ interaction inhibitor 1 [CAS 493028-20-9]
Runx1-CBFβ interaction inhibitor 1 [CAS 493028-20-9]
SKU:QM-0060475-01
£294.22 GBP
Quantity
Couldn't load pickup availability
Request quote or documents
![Runx1-CBFβ interaction inhibitor 1 [CAS 493028-20-9]](http://quantimol.com/cdn/shop/files/quantimol-021.png?v=1773515276&width=1445)
Product Details
-
Description
Runx1-CBFβ interaction inhibitor 1 is an allosteric inhibitior of Runt domain-CBFb interaction (IC50=3.2 μM) [1].
-
CAS Number
[493028-20-9]
-
Molecular Formula
C12H14N2OS
-
Molecular Weight
234.32
-
Smiles
COC(C=C1)=CC=C1C2=C(CC)SC(N)=N2
-
Target
RUNX
-
Solubility
10 mM in DMSO
-
Shipping Conditions
Room temperature
-
Hazard Statement
H302-H315-H319-H335
-
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362-P403+P233-P405-P501
Related Products
- QM-0025230 β-catenin inhibitory peptoid [CAS 2579070-02-1]
- QM-0023369 α-Synuclein inhibitor 14 [CAS 408324-13-0]
- QM-0015918 β2AR agonist 5 [CAS 2759727-47-2]
- QM-0015098 α2AR agonist 2 [CAS 719277-27-7]
- QM-0013035 α-Synuclein inhibitor 15 [CAS 414880-30-1]
- QM-0013016 αMβ2 integrin agonist-1
- QM-0013015-01 α5β1 integrin agonist-2
- QM-0013014 α4β1 antagonist-1
- QM-0012730-01 YTHDF2 ligand-1 [CAS 3093182-34-1]
- QM-0009574 α5-GABAA receptor modulator 1
Other industry favorites
- QM-0025230 β-catenin inhibitory peptoid [CAS 2579070-02-1]
- QM-0023369 α-Synuclein inhibitor 14 [CAS 408324-13-0]
- QM-0141339-01 δ-Secretase inhibitor 11 [CAS 842964-18-5]
- QM-0196447-01 α2β1 Integrin Ligand Peptide (TFA)
- QM-0065091 μ opioid receptor agonist 1 [CAS 2667632-83-7]
- QM-0070729 β-Catenin modulator-5 [CAS 902168-07-4]
- QM-0150540-01 β-FXR antagonist 1 [CAS 2295804-92-9]
- QM-0153508-01 α-Synuclein inhibitor 11
- QM-0122210 δ opioid receptor antagonist 1
- QM-0121938 α-Synuclein inhibitor 13
Runx1-CBFβ interaction inhibitor 1 [CAS 493028-20-9]
Runx1-CBFβ interaction inhibitor 1 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.